Biofrontera Inc. (BFRI:NASDAQ) closed at $0.806 on October 19, 2026, down 1.94% on the day. The stock trades 51.5% below its 52-week high of $1.66 and 45.2% above its 52-week low of $0.555. Over the past year, it lost 18.6%. Biofrontera Inc. is part of the Health Care sector.
In 252 trading sessions since October 17, 2025, BFRI closed higher on 117 days (46%). Its best day was January 2, 2026 (+27.19%) and its worst was December 31, 2025 (-20.83%). The stock moved 10% or more in a single session 13 times. It opened at least 5% above the previous day's high 2 times.
Biofrontera Inc is a biopharmaceutical company specializing in the commercialization of pharmaceutical products for the treatment of dermatological conditions, diseases caused by exposure to sunlight that result in sun damage to the skin. Its licensed products focus on the treatment of actinic keratoses, which are skin lesions that can sometimes lead to skin cancer. It also markets a topical antibiotic for the treatment of impetigo, a bacterial skin infection.
Find more stocks like BFRI with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.